Provectus Biopharmaceuticals, Inc. (OTCMKTS:PVCT – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 58,700 shares, a growth of 3,568.8% from the September 15th total of 1,600 shares. Based on an average daily volume of 634,100 shares, the short-interest ratio is presently 0.1 days.
Provectus Biopharmaceuticals Stock Performance
OTCMKTS PVCT traded up $0.00 during trading on Friday, reaching $0.11. The company’s stock had a trading volume of 63,690 shares, compared to its average volume of 254,300. Provectus Biopharmaceuticals has a 12 month low of $0.04 and a 12 month high of $0.22. The firm has a 50 day moving average price of $0.10 and a 200 day moving average price of $0.14.
About Provectus Biopharmaceuticals
Read More
- Five stocks we like better than Provectus Biopharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Stock Dividend Cuts Happen Are You Ready?
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Industrial Products Stocks Investing
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Provectus Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provectus Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.